American International Group, Inc. Clearside Biomedical, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$0.97 - $1.42 $17,294 - $25,317	-17,829 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$1.1 - $1.74 $635 - $1,005	-578 Reduced 3.14%	17,829 $25,000
Q4 2018 Feb 13, 2019	SELL	$1.0 - $6.12 $142 - $869	-142 Reduced 0.77%	18,407 $20,000
Q3 2018 Nov 09, 2018	BUY	$6.03 - $11.24 $2,026 - $3,776	336 Added 1.84%	18,549 $114,000
Q2 2018 Aug 08, 2018	BUY	$8.91 - $14.54 $44,514 - $72,641	4,996 Added 37.8%	18,213 $195,000
Q1 2018 May 07, 2018	SELL	$5.57 - $14.28 $3,960 - $10,153	-711 Reduced 5.1%	13,217 $142,000
Q4 2017 Feb 09, 2018	BUY	$5.78 - $9.12 $375 - $592	65 Added 0.47%	13,928 $97,000
Q3 2017 Nov 09, 2017	BUY	$6.73 - $8.74 $93,297 - $121,162	13,863	13,863 $121,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $69.8M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.